Title : Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.

Pub. Date : 2020 Jun

PMID : 32273207






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 CONCLUSION: Treatment with nab-paclitaxel in first- or further-line of metastatic HR-positive/HER2-negative breast cancer resulted in similar effectiveness and safety, irrespective of age. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens